BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 18204803)

  • 1. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
    Weintraub D; Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Siderowf A; Aarsland D; Barone P; Burn D; Chahine LM; Eberling J; Espay AJ; Foster ED; Leverenz JB; Litvan I; Richard I; Troyer MD; Hawkins KA;
    Mov Disord; 2015 Jun; 30(7):919-27. PubMed ID: 25737166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.
    van Steenoven I; Aarsland D; Hurtig H; Chen-Plotkin A; Duda JE; Rick J; Chahine LM; Dahodwala N; Trojanowski JQ; Roalf DR; Moberg PJ; Weintraub D
    Mov Disord; 2014 Dec; 29(14):1809-15. PubMed ID: 25381961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS.
    Goldman JG; Stebbins GT; Leung V; Tilley BC; Goetz CG
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1135-9. PubMed ID: 25150770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Neuropsychological Tests to Screen for Dementia in Chinese Patients With Parkinson's Disease.
    Qiao J; Wang X; Lu W; Cao H; Qin X
    Am J Alzheimers Dis Other Demen; 2016 Jun; 31(4):368-74. PubMed ID: 26646116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild cognitive impairment in patients with Parkinson´s disease and the analysis of associated factors.
    Kobak Tur E; Ari BC
    Neurol Res; 2023 Dec; 45(12):1161-1168. PubMed ID: 37743634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias.
    Hinkle JT; Perepezko K; Rosenthal LS; Mills KA; Pantelyat A; Mari Z; Tochen L; Bang JY; Gudavalli M; Yoritomo N; Butala A; Bakker CC; Johnson V; Moukheiber E; Dawson TM; Pontone GM
    Parkinsonism Relat Disord; 2018 Feb; 47():50-56. PubMed ID: 29198499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment and dementia in young onset Parkinson's disease.
    Santos-García D; de Deus Fonticoba T; Cores Bartolomé C; Feal Painceiras MJ; García Díaz I; Íñiguez Alvarado MC; Paz JM; Jesús S; Cosgaya M; García Caldentey J; Caballol N; Legarda I; Hernández Vara J; Cabo I; López Manzanares L; González Aramburu I; Ávila Rivera MA; Gómez Mayordomo V; Nogueira V; Dotor García-Soto J; Borrué C; Solano Vila B; Álvarez Sauco M; Vela L; Escalante S; Cubo E; Mendoza Z; Martínez Castrillo JC; Sánchez Alonso P; Alonso Losada MG; López Ariztegui N; Gastón I; Kulisevsky J; Seijo M; Valero C; Alonso Redondo R; Buongiorno MT; Ordás C; Menéndez-González M; McAfee D; Martinez-Martin P; Mir P;
    J Neurol; 2023 Dec; 270(12):5793-5812. PubMed ID: 37578489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addenbrooke's cognitive examination III: diagnostic utility for detecting mild cognitive impairment and dementia in Parkinson's disease.
    Sousa NMF; Brucki SMD
    Arq Neuropsiquiatr; 2023 Feb; 81(2):155-163. PubMed ID: 36863401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for dementia in Parkinson's Disease - the overuse of anticholinergic drugs.
    Malkiewicz JJ; Kasprzyk AG; Waksmundzki D; Węgrzynek J; Chmiela T; Siuda J
    Neurol Neurochir Pol; 2023; 57(5):405-413. PubMed ID: 37357543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease.
    Holden SK; Medina LD; Hoyt B; Sillau SH; Berman BD; Goldman JG; Weintraub D; Kluger BM
    Mov Disord; 2018 Nov; 33(11):1760-1768. PubMed ID: 30306618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.
    Liu G; Locascio JJ; Corvol JC; Boot B; Liao Z; Page K; Franco D; Burke K; Jansen IE; Trisini-Lipsanopoulos A; Winder-Rhodes S; Tanner CM; Lang AE; Eberly S; Elbaz A; Brice A; Mangone G; Ravina B; Shoulson I; Cormier-Dequaire F; Heutink P; van Hilten JJ; Barker RA; Williams-Gray CH; Marinus J; Scherzer CR; ; ; ; ; ; ;
    Lancet Neurol; 2017 Aug; 16(8):620-629. PubMed ID: 28629879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clock drawing test in elderly individuals with different education levels: correlation with clinical dementia rating.
    Cecato JF; Fiorese B; Montiel JM; Bartholomeu D; Martinelli JE
    Am J Alzheimers Dis Other Demen; 2012 Dec; 27(8):620-4. PubMed ID: 23118201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease.
    Vu TC; Nutt JG; Holford NH
    Br J Clin Pharmacol; 2012 Aug; 74(2):284-95. PubMed ID: 22300470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of dementia rating scales in Parkinson's disease dementia.
    Harvey PD; Ferris SH; Cummings JL; Wesnes KA; Hsu C; Lane RM; Tekin S
    Am J Alzheimers Dis Other Demen; 2010 Mar; 25(2):142-8. PubMed ID: 19359706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective Cognitive Complaints in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Siciliano M; Tessitore A; Morgante F; Goldman JG; Ricciardi L
    Mov Disord; 2024 Jan; 39(1):17-28. PubMed ID: 38173220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease.
    Malek N; Lawton MA; Swallow DM; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Hardy J; Morris HR; Williams NM; Wood N; Ben-Shlomo Y; Grosset DG;
    Mov Disord; 2016 Oct; 31(10):1518-1526. PubMed ID: 27324570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everyday action impairment in Parkinson's disease dementia.
    Giovannetti T; Britnell P; Brennan L; Siderowf A; Grossman M; Libon DJ; Bettcher BM; Rouzard F; Eppig J; Seidel GA
    J Int Neuropsychol Soc; 2012 Sep; 18(5):787-98. PubMed ID: 22621995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apathy and depressive mood in nursing home patients with early-onset dementia.
    Leontjevas R; van Hooren S; Waterink W; Mulders A
    Am J Alzheimers Dis Other Demen; 2009; 24(4):341-8. PubMed ID: 19346502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in Parkinson's disease.
    Verbaan D; Marinus J; Visser M; van Rooden SM; Stiggelbout AM; Middelkoop HA; van Hilten JJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1182-7. PubMed ID: 17442759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.